The antitumor mechanisms of Shikonin may be associated with suppression of PKM2 mediated aerobic glycolysis and inhibition of PKM2/STAT3 signaling pathway in ESCC. The gene discussed is PKM; the disease is esophageal squamous cell carcinoma.